Genprex, Inc., formerly known as Convergen LifeSciences, Inc., announced today that its first product candidate, the nanomolecular cancer therapy CNVN202, will be branded as Oncoprex(TM)

BETHESDA, Md., Aug. 3 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc.

HOUSTON, Nov. 4 /PRNewswire/ -- US Oncology today announced that OncologyRx Care Advantage, a national oral oncology specialty pharmacy, has exceeded the $10 million mark in assisting more than 2,000 patients with drug co-pays since the launch of Care Advantage in August 2006.

Pro-Pharmaceuticals, Inc. (Amex: PRW), a company "

Research and Markets (http://www.researchandmarket